|
- Cancer Drugs Fund - NHS England
The Cancer Drugs Fund (CDF) is a source of funding for cancer drugs in England On 29 July 2016, a new approach to the appraisal and funding of cancer drugs in England began operating
- Cancer Drugs Fund (CDF) - Cancer Research UK
What is the Cancer Drugs Fund? The CDF is part of the NICE process for reviewing new cancer medicines NICE aims to review all new cancer medicines within 90 days of them getting a licence for use in England It also assesses medicines used to treat rare cancers NICE makes one of 5 decisions about whether a medicine should be available:
- Cancer Drugs Fund - Wikipedia
The Cancer Drugs Fund (CDF) was introduced in England in 2011 It was established in order to provide a means by which National Health Service (NHS) patients in England could receive cancer drugs that had been rejected by National Institute for Health and Care Excellence because they were not cost effective
- 英国癌症药物基金改革及对医保创新药支付政策的启示
<sec>目的通过对英国癌症药物基金（Cancer Drugs Fund，CDF）的形成背景、运行机制及改革中优化管理策略进行批判借鉴研究，为中国创新药准入及管理政策的制定提供参考。
- Which way now for the Cancer Drugs Fund? - The BMJ
The Cancer Drugs Fund was created in 2010 by the coalition government to pay for new cancer drugs that the NHS would otherwise not have provided because the National Institute for Health and Care Excellence (NICE) considered they were not cost efective
- Do patient access schemes for high-cost cancer drugs deliver . . . - PubMed
Background: The NHS Cancer Drugs Fund (CDF) was established in 2010 to reduce delays and improve access to cancer drugs, including those that had been previously appraised but not approved by NICE (National Institute for Health and Care Excellence)
- NICE’s track record in cancer drugs: the impact of the . . . - pharmaphorum
Cancer Research UK have suggested that CDF 2 0 is a success on the basis that drugs paid for under CDF 1 0 were reviewed and NICE approved almost all of them
- Cancer Drugs Fund list - NHS England
This is the most recent version of the national Cancer Drugs Fund list, and replaces any earlier versions It contains updates to the previous list, as well as new drugs and indications which have been added to the Cancer Drugs Fund
|
|
|